NO2564846T3 - - Google Patents

Info

Publication number
NO2564846T3
NO2564846T3 NO12177257A NO12177257A NO2564846T3 NO 2564846 T3 NO2564846 T3 NO 2564846T3 NO 12177257 A NO12177257 A NO 12177257A NO 12177257 A NO12177257 A NO 12177257A NO 2564846 T3 NO2564846 T3 NO 2564846T3
Authority
NO
Norway
Application number
NO12177257A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2564846T3 publication Critical patent/NO2564846T3/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
NO12177257A 2007-12-10 2008-12-10 NO2564846T3 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1276207P 2007-12-10 2007-12-10
EP08860419A EP2237778A2 (en) 2007-12-10 2008-12-10 Methods of treating hematologic cancers using pnp inhibitors such as forodesine in combination with alkylating agents or anti-cd20 agents

Publications (1)

Publication Number Publication Date
NO2564846T3 true NO2564846T3 (no) 2018-07-28

Family

ID=40431122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO12177257A NO2564846T3 (no) 2007-12-10 2008-12-10

Country Status (26)

Country Link
US (5) US20110038858A1 (no)
EP (3) EP2564846B1 (no)
JP (2) JP5543362B2 (no)
KR (1) KR101545367B1 (no)
CN (2) CN101969947B (no)
AU (1) AU2008335167B2 (no)
CA (2) CA2881035C (no)
CY (1) CY1120203T1 (no)
DK (1) DK2564846T3 (no)
EA (2) EA025340B1 (no)
ES (1) ES2670714T3 (no)
GE (2) GEP20135855B (no)
HR (1) HRP20180712T1 (no)
HU (1) HUE037342T2 (no)
IL (1) IL206264A (no)
LT (1) LT2564846T (no)
MY (2) MY193789A (no)
NO (1) NO2564846T3 (no)
NZ (3) NZ586416A (no)
PH (1) PH12014501454B1 (no)
PL (1) PL2564846T3 (no)
PT (1) PT2564846T (no)
SG (1) SG188870A1 (no)
SI (1) SI2564846T1 (no)
UA (2) UA104579C2 (no)
WO (1) WO2009076455A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616129B2 (en) 2013-06-22 2017-04-11 Nitor Therapeutics Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency
ES2909662T3 (es) * 2014-08-07 2022-05-09 Laevoroc Immunology Ag Composiciones que comprenden un inhibidor de PNP para uso en el tratamiento de la recaída de malignidad después de un trasplante de células madre hematopoyéticas

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US199697A (en) 1878-01-29 Improvement in butter-sharers
EP0460116B1 (en) 1989-02-27 1997-08-27 Biocryst Pharmaceuticals Inc. 9-substituted-8-unsubstituted-9-deazaguanines
US5008265A (en) 1989-10-31 1991-04-16 Biocryst, Inc. 2-amino-7-(alicyclomethyl)-3H,5H,-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US5008270A (en) 1989-10-31 1991-04-16 Biocryst, Inc. 2-amino-7-(heterocyclomethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US4985433A (en) 1989-10-31 1991-01-15 Biocryst, Inc. 2-amino-7-(pyridinylmethyl)-3H,5H-pyrrolo[3,2-d]pyrimidin-4-ones and pharmaceutical uses and compositions containing the same
US4985434A (en) 1989-10-31 1991-01-15 Biocryst, Inc. 7-substituted derivatives of 2-amino-3H,5H-pyrrolo(3,2-d)pyrimidin-4-ones and pharamceutical uses and compositions containing the same
US5595721A (en) * 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
AU695032B2 (en) * 1994-10-05 1998-08-06 Darwin Discovery Limited Purine and guanine compounds as inhibitors of PNP
EP1616572B1 (en) 1998-11-09 2010-09-01 Biogen Idec Inc. Chimeric anti-CD20 antibody, rituxan, for use in the treatment of chronic lymphocytic leukemia
US6387923B2 (en) * 2000-03-22 2002-05-14 Biocryst Pharmacueticals, Inc. Imminoribitol PNP inhibitors, preparation thereof and use thereof
DE10306724A1 (de) * 2002-02-28 2003-09-18 G O T Therapeutics Gmbh Vesikuläre Verkapselung von Bendamustin
WO2003097052A2 (en) * 2002-05-17 2003-11-27 Celgene Corporation Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
JP5180824B2 (ja) * 2005-06-29 2013-04-10 スレッシュホールド ファーマシューティカルズ， インコーポレイテッド ホスホルアミデートアルキル化剤プロドラッグ
CA2647282A1 (en) 2006-04-05 2007-10-11 Pfizer Products Inc. Ctla4 antibody combination therapy

Also Published As

Publication number Publication date
EA201370055A1 (ru) 2013-11-29
US20240100055A1 (en) 2024-03-28
US11110092B2 (en) 2021-09-07
US20220040188A1 (en) 2022-02-10
JP2011506345A (ja) 2011-03-03
EA201070669A1 (ru) 2010-12-30
US20190255058A1 (en) 2019-08-22
CN103736091A (zh) 2014-04-23
NZ617989A (en) 2015-05-29
KR20100101139A (ko) 2010-09-16
US20110038858A1 (en) 2011-02-17
IL206264A0 (en) 2010-12-30
GEP20156288B (en) 2015-05-25
PT2564846T (pt) 2018-05-23
NZ586416A (en) 2012-07-27
LT2564846T (lt) 2018-05-10
PH12014501454A1 (en) 2016-01-18
NZ601072A (en) 2014-01-31
MY193789A (en) 2022-10-27
IL206264A (en) 2017-04-30
EA025340B1 (ru) 2016-12-30
EP2237778A2 (en) 2010-10-13
US20140178372A1 (en) 2014-06-26
AU2008335167A1 (en) 2009-06-18
WO2009076455A3 (en) 2009-08-27
SI2564846T1 (en) 2018-06-29
KR101545367B1 (ko) 2015-08-18
ES2670714T3 (es) 2018-05-31
EA018415B1 (ru) 2013-07-30
CA2881035A1 (en) 2009-06-18
CA2708606C (en) 2015-04-28
PL2564846T3 (pl) 2018-08-31
CN101969947B (zh) 2014-10-22
EP2564846B1 (en) 2018-02-28
WO2009076455A2 (en) 2009-06-18
JP5543362B2 (ja) 2014-07-09
JP2014094962A (ja) 2014-05-22
MY163023A (en) 2017-07-31
PH12014501454B1 (en) 2016-01-18
AU2008335167B2 (en) 2014-02-13
CN101969947A (zh) 2011-02-09
UA109571C2 (uk) 2015-09-10
GEP20135855B (en) 2013-06-25
UA104579C2 (uk) 2014-02-25
CA2881035C (en) 2019-04-16
HRP20180712T1 (hr) 2018-06-15
EP2564846A1 (en) 2013-03-06
HUE037342T2 (hu) 2018-08-28
SG188870A1 (en) 2013-04-30
DK2564846T3 (en) 2018-05-22
CN103736091B (zh) 2016-09-28
CA2708606A1 (en) 2009-06-18
EP2581083A1 (en) 2013-04-17
CY1120203T1 (el) 2018-12-12

Similar Documents

Publication Publication Date Title
CN104335712B8 (no)
NO2564846T3 (no)
CN300729475S (zh) 包装盒(冒险)
CN300726687S (zh) 晒物架(旦型3)
CN300726086S (zh) 钥匙圈
CN300726267S (zh) 墙纸(26)
CN300726282S (zh) 包装纸
CN300726283S (zh) 玻璃板(第六印象)
CN300726363S (zh) 婴儿床
CN300726666S (zh) 电磁茶炉
CN300726847S (zh) 酒瓶
CN300726955S (zh) 包装盒(黄金搭档儿童青少年型)
CN300726969S (zh) 酒类包装盒(8)
CN300727132S (zh) 包装袋(田七纯棉洗衣粉)
CN300727525S (zh) 漏电断路器(tgb7l-40)
CN300727568S (zh) 扬声器(2)
CN300727586S (zh) 迷你音箱(cql1065)
CN300727612S (zh) 显示器(五)
CN300727777S (zh) 数控雕铣机床
CN300727985S (zh) 标签(jmy-016)
CN300727988S (zh) 标签(jmy-025)
CN300728191S (zh) 暖炉(pz-ts1)
CN300728202S (zh) 工业暖风机(ifj04-150)
CN300728347S (zh) 垫块
CN300728367S (zh) 充电灯(3)